Palvella Therapeutics (PVLA) Preferred Shares (2016 - 2017)
Palvella Therapeutics' (PVLA) quarterly Preferred Shares came in at $5.0 in Q3 2017, little changed year-on-year from $5.0 in Q3 2016, and little changed on a QoQ basis from $5.0 in Q2 2017.
Palvella Therapeutics (PVLA) Preferred Shares (2016 - 2017) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Preferred Shares data on file, last reported at $5.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Palvella Therapeutics | 1.84 Bn | 1.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 5.00 |
| Jun 30, 2017 | 5.00 |
| Mar 31, 2017 | 5.00 |
| Sep 30, 2016 | 5.00 |
| Jun 30, 2016 | 5.00 |